Literature DB >> 21533772

Activation and maturation of SARS-CoV main protease.

Bin Xia1, Xue Kang.   

Abstract

The worldwide outbreak of the severe acute respiratory syndrome (SARS) in 2003 was due to the transmission of SARS coronavirus (SARS-CoV). The main protease (M(pro)) of SARS-CoV is essential for the viral life cycle, and is considered to be an attractive target of anti-SARS drug development. As a key enzyme for proteolytic processing of viral polyproteins to produce functional non-structure proteins, M(pro) is first auto-cleaved out of polyproteins. The monomeric form of M(pro) is enzymatically inactive, and it is activated through homo-dimerization which is strongly affected by extra residues to both ends of the mature enzyme. This review provides a summary of the related literatures on the study of the quaternary structure, activation, and self-maturation of M(pro) over the past years.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21533772      PMCID: PMC4875205          DOI: 10.1007/s13238-011-1034-1

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  42 in total

1.  SARS CoV main proteinase: The monomer-dimer equilibrium dissociation constant.

Authors:  Vito Graziano; William J McGrath; Lin Yang; Walter F Mangel
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

2.  Design of wide-spectrum inhibitors targeting coronavirus main proteases.

Authors:  Haitao Yang; Weiqing Xie; Xiaoyu Xue; Kailin Yang; Jing Ma; Wenxue Liang; Qi Zhao; Zhe Zhou; Duanqing Pei; John Ziebuhr; Rolf Hilgenfeld; Kwok Yung Yuen; Luet Wong; Guangxia Gao; Saijuan Chen; Zhu Chen; Dawei Ma; Mark Bartlam; Zihe Rao
Journal:  PLoS Biol       Date:  2005-09-06       Impact factor: 8.029

3.  Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery.

Authors:  Valerie Grum-Tokars; Kiira Ratia; Adrian Begaye; Susan C Baker; Andrew D Mesecar
Journal:  Virus Res       Date:  2007-03-29       Impact factor: 3.303

4.  Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode.

Authors:  Shuai Chen; Felix Jonas; Can Shen; Rolf Hilgenfeld; Rolf Higenfeld
Journal:  Protein Cell       Date:  2010-02-07       Impact factor: 14.870

5.  Only one protomer is active in the dimer of SARS 3C-like proteinase.

Authors:  Hao Chen; Ping Wei; Changkang Huang; Lei Tan; Ying Liu; Luhua Lai
Journal:  J Biol Chem       Date:  2006-03-24       Impact factor: 5.157

6.  Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease.

Authors:  Wen-Chi Hsu; Hui-Chuan Chang; Chi-Yuan Chou; Pui-Jen Tsai; Pei-In Lin; Gu-Gang Chang
Journal:  J Biol Chem       Date:  2005-04-14       Impact factor: 5.157

Review 7.  Coronaviruses post-SARS: update on replication and pathogenesis.

Authors:  Stanley Perlman; Jason Netland
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

8.  Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer.

Authors:  Ting Xu; Amy Ooi; Hooi Chen Lee; Rupert Wilmouth; Ding Xiang Liu; Julien Lescar
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-10-20

9.  Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage.

Authors:  Eric J Snijder; Peter J Bredenbeek; Jessika C Dobbe; Volker Thiel; John Ziebuhr; Leo L M Poon; Yi Guan; Mikhail Rozanov; Willy J M Spaan; Alexander E Gorbalenya
Journal:  J Mol Biol       Date:  2003-08-29       Impact factor: 5.469

10.  The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain.

Authors:  Jiahai Shi; Jianxing Song
Journal:  FEBS J       Date:  2006-03       Impact factor: 5.542

View more
  41 in total

1.  SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity.

Authors:  Tomonari Muramatsu; Chie Takemoto; Yong-Tae Kim; Hongfei Wang; Wataru Nishii; Takaho Terada; Mikako Shirouzu; Shigeyuki Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-31       Impact factor: 11.205

2.  Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease.

Authors:  B J Oso; I F Olaoye; S O Omeike
Journal:  Arch Razi Inst       Date:  2021-09-01

3.  Evolution of SARS-CoV-2 in Spain during the First Two Years of the Pandemic: Circulating Variants, Amino Acid Conservation, and Genetic Variability in Structural, Non-Structural, and Accessory Proteins.

Authors:  Paloma Troyano-Hernáez; Roberto Reinosa; África Holguín
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

Review 4.  Paxlovid: Mechanism of Action, Synthesis, and In Silico Study.

Authors:  Mahrokh Marzi; Mohammad Kazem Vakil; Maryam Bahmanyar; Elham Zarenezhad
Journal:  Biomed Res Int       Date:  2022-07-07       Impact factor: 3.246

5.  Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators.

Authors:  Lorenza Fagnani; Lisaurora Nazzicone; Pierangelo Bellio; Nicola Franceschini; Donatella Tondi; Andrea Verri; Sabrina Petricca; Roberto Iorio; Gianfranco Amicosante; Mariagrazia Perilli; Giuseppe Celenza
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-04

6.  Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance.

Authors:  Xufang Deng; Sarah E StJohn; Heather L Osswald; Amornrat O'Brien; Bridget S Banach; Katrina Sleeman; Arun K Ghosh; Andrew D Mesecar; Susan C Baker
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

7.  Purification, crystallization and preliminary X-ray analysis of nonstructural protein 2 (nsp2) from avian infectious bronchitis virus.

Authors:  Kun Yu; Zhenhua Ming; Yuanyuan Li; Cheng Chen; Zehua Bao; Zhilin Ren; Bofeng Liu; Wei Tao; Zihe Rao; Zhiyong Lou
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-05-24

8.  The inactivation mechanism of chemical disinfection against SARS-CoV-2: from MD and DFT perspectives.

Authors:  Chunjian Tan; Chenshan Gao; Quan Zhou; Willem Van Driel; Huaiyu Ye; Guoqi Zhang
Journal:  RSC Adv       Date:  2020-11-06       Impact factor: 4.036

Review 9.  A Crystallographic Snapshot of SARS-CoV-2 Main Protease Maturation Process.

Authors:  G D Noske; A M Nakamura; V O Gawriljuk; R S Fernandes; G M A Lima; H V D Rosa; H D Pereira; A C M Zeri; A F Z Nascimento; M C L C Freire; D Fearon; A Douangamath; F von Delft; G Oliva; A S Godoy
Journal:  J Mol Biol       Date:  2021-06-24       Impact factor: 6.151

Review 10.  Broad-spectrum antiviral agents.

Authors:  Jun-Da Zhu; Wen Meng; Xiao-Jia Wang; Hwa-Chain R Wang
Journal:  Front Microbiol       Date:  2015-05-22       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.